• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

山奈素的抗癌潜力:从机制研究到协同作用的视角。

Anticancer potential of oroxylin A: from mechanistic insight to synergistic perspectives.

机构信息

Department of Biotechnology, Maharishi Markandeshwar Engineering College, Maharishi Markandeshwar (Deemed to Be University), Mullana-Ambala, Haryana, 133207, India.

Department of Medical Laboratory Technology, University Institute of Applied Health Sciences, Chandigarh University, Gharuan, Mohali, 140413, Punjab, India.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 2023 Feb;396(2):191-212. doi: 10.1007/s00210-022-02298-0. Epub 2022 Oct 10.

DOI:10.1007/s00210-022-02298-0
PMID:36214865
Abstract

Oroxylin A (OA), a well-known constituent of the root of Scutellariae plants, has been used in ethnomedicine already for centuries in treating various neoplastic disorders. However, only recent molecular studies have revealed the different mechanisms behind its action, demonstrating antiproliferative, anti-inflammatory, and proapoptotic effects, restricting also the spread of cancer cells to distant organs. A variety of cellular targets and modulated signal transduction pathways regulated by OA have been determined in diverse cells derived from different malignant tissues. In this review article, these anticancer activities are thoroughly described, representing OA as a potential lead structure for the design of novel more potent anticancer medicines. In addition, co-effects of this natural compound with conventional anticancer agents are analyzed and the advantages provided by nanotechnological methods for more efficient application of OA are discussed. In this way, OA might represent an excellent example of using ethnopharmacological knowledge for designing modern medicines.

摘要

梓醇 A(OA)是黄芩植物根部的一种著名成分,已经在传统医学中使用了几个世纪,用于治疗各种肿瘤疾病。然而,只有最近的分子研究揭示了其作用背后的不同机制,表明其具有抗增殖、抗炎和促凋亡作用,还可以限制癌细胞向远处器官的扩散。OA 在源自不同恶性组织的多种细胞中确定了多种细胞靶标和调节的信号转导途径。在这篇综述文章中,详细描述了这些抗癌活性,将 OA 作为设计新型更有效的抗癌药物的潜在先导结构。此外,还分析了这种天然化合物与传统抗癌药物的协同作用,并讨论了纳米技术方法为更有效地应用 OA 提供的优势。通过这种方式,OA 可能代表了利用民族药理学知识设计现代药物的一个极好范例。

相似文献

1
Anticancer potential of oroxylin A: from mechanistic insight to synergistic perspectives.山奈素的抗癌潜力:从机制研究到协同作用的视角。
Naunyn Schmiedebergs Arch Pharmacol. 2023 Feb;396(2):191-212. doi: 10.1007/s00210-022-02298-0. Epub 2022 Oct 10.
2
Sesamol as a potent anticancer compound: from chemistry to cellular interactions.芝麻酚作为一种有效的抗癌化合物:从化学到细胞相互作用
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul;397(7):4961-4979. doi: 10.1007/s00210-023-02919-2. Epub 2024 Jan 5.
3
Oroxylin A inhibits carcinogen-induced skin tumorigenesis through inhibition of inflammation by regulating SHCBP1 in mice.梓醇通过调控 SHCBP1 抑制炎症抑制致癌物诱导的皮肤肿瘤发生。
Int Immunopharmacol. 2020 Mar;80:106123. doi: 10.1016/j.intimp.2019.106123. Epub 2020 Jan 9.
4
Oroxylin A, a natural compound, mitigates the negative effects of TNFα-treated acute myelogenous leukemia cells.盐酸小檗碱 A 是一种天然化合物,可减轻 TNFα 处理的急性髓系白血病细胞的负面影响。
Carcinogenesis. 2018 Oct 8;39(10):1292-1303. doi: 10.1093/carcin/bgy004.
5
Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells.木犀草素A通过SIRT3介导的去乙酰化作用促进PTEN介导的MDM2转录负调控,以稳定p53并抑制野生型p53癌细胞中的糖酵解。
J Hematol Oncol. 2015 Apr 23;8:41. doi: 10.1186/s13045-015-0137-1.
6
Oroxylin A inhibits invasion and migration through suppressing ERK/GSK-3β signaling in snail-expressing non-small-cell lung cancer cells.木犀草素A通过抑制表达蜗牛蛋白的非小细胞肺癌细胞中的ERK/GSK-3β信号通路来抑制侵袭和迁移。
Mol Carcinog. 2016 Dec;55(12):2121-2134. doi: 10.1002/mc.22456. Epub 2016 Jan 6.
7
The role of Nrf2 and apoptotic signaling pathways in oroxylin A-mediated responses in HCT-116 colorectal adenocarcinoma cells and xenograft tumors.姜黄素 A 介导的 Nrf2 和凋亡信号通路在 HCT-116 结肠直肠腺癌细胞和异种移植肿瘤中的作用。
Anticancer Drugs. 2012 Jul;23(6):651-8. doi: 10.1097/CAD.0b013e3283512703.
8
Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF-B Signaling Pathway in Human Breast Cancer Cells.山奈素通过 NF-B 信号通路抑制人乳腺癌细胞的增殖、迁移和 EMT。
Biomed Res Int. 2019 Jun 23;2019:9241769. doi: 10.1155/2019/9241769. eCollection 2019.
9
Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling.Beclin 1 介导的自噬在肝癌细胞中的作用:通过抑制 mTOR 信号通路,奥罗西林 A 的抗癌效率的影响。
Cell Signal. 2012 Aug;24(8):1722-32. doi: 10.1016/j.cellsig.2012.04.009. Epub 2012 Apr 25.
10
Cellular and molecular mechanisms of oroxylin A in cancer therapy: Recent advances.奥洛西林 A 在癌症治疗中的细胞和分子机制:最新进展。
Eur J Pharmacol. 2024 Apr 15;969:176452. doi: 10.1016/j.ejphar.2024.176452. Epub 2024 Feb 28.

引用本文的文献

1
Oroxylin A may promote cell apoptosis and inhibit epithelial-mesenchymal transition in endometrial cancer, associated with the ERβ/PI3K/AKT pathway.木犀草素A可能促进子宫内膜癌细胞凋亡并抑制上皮-间质转化,这与雌激素受体β/磷脂酰肌醇-3激酶/蛋白激酶B信号通路有关。
Sci Rep. 2025 Apr 10;15(1):12225. doi: 10.1038/s41598-025-97122-z.
2
An updated review summarizing the anticancer potential of flavonoids via targeting NF-kB pathway.一篇最新综述总结了黄酮类化合物通过靶向核因子-κB通路的抗癌潜力。
Front Pharmacol. 2025 Jan 6;15:1513422. doi: 10.3389/fphar.2024.1513422. eCollection 2024.
3
Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research.

本文引用的文献

1
Immunotherapeutics in lung cancers: from mechanistic insight to clinical implications and synergistic perspectives.肺癌免疫疗法:从机制洞察到临床意义及协同作用视角
Mol Biol Rep. 2023 Mar;50(3):2685-2700. doi: 10.1007/s11033-022-08180-9. Epub 2022 Dec 19.
2
Ethnodermatological use of medicinal plants in India: From ayurvedic formulations to clinical perspectives - A review.印度药用植物的民族皮肤病学用途:从阿育吠陀制剂到临床视角——综述。
J Ethnopharmacol. 2022 Feb 10;284:114744. doi: 10.1016/j.jep.2021.114744. Epub 2021 Oct 14.
3
Pharmacological basis and new insights of taxifolin: A comprehensive review.
神经母细胞瘤诊断、治疗与研究的新趋势
Mol Neurobiol. 2025 May;62(5):6423-6466. doi: 10.1007/s12035-024-04680-w. Epub 2025 Jan 13.
4
The Role of Phytonutrient Kaempferol in the Prevention of Gastrointestinal Cancers: Recent Trends and Future Perspectives.植物营养素山奈酚在预防胃肠道癌症中的作用:最新趋势与未来展望
Cancers (Basel). 2024 Apr 27;16(9):1711. doi: 10.3390/cancers16091711.
5
Nano-biotechnology in tumour and cancerous disease: A perspective review.纳米生物技术在肿瘤和癌症疾病中的应用:综述展望
J Cell Mol Med. 2023 Mar;27(6):737-762. doi: 10.1111/jcmm.17677. Epub 2023 Feb 24.
金雀异黄素的药理学基础及新认识:全面综述。
Biomed Pharmacother. 2021 Oct;142:112004. doi: 10.1016/j.biopha.2021.112004. Epub 2021 Aug 10.
4
Exploring Phytochemicals for Combating Antibiotic Resistance in Microbial Pathogens.探索植物化学物质以对抗微生物病原体中的抗生素耐药性
Front Pharmacol. 2021 Jul 21;12:720726. doi: 10.3389/fphar.2021.720726. eCollection 2021.
5
The Multifaceted Role of Flavonoids in Cancer Therapy: Leveraging Autophagy with a Double-Edged Sword.类黄酮在癌症治疗中的多方面作用:用双刃剑利用自噬
Antioxidants (Basel). 2021 Jul 19;10(7):1138. doi: 10.3390/antiox10071138.
6
Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling.新型 CDK9 抑制剂山奈酚通过破坏 MDM2 和 SIRT1 信号通路促进野生型 P53 稳定性并防止肝细胞癌进展。
Acta Pharmacol Sin. 2022 Apr;43(4):1033-1045. doi: 10.1038/s41401-021-00708-2. Epub 2021 Jun 29.
7
Oroxylin A inhibits the migration of hepatocellular carcinoma cells by inducing NAG-1 expression.梓醇 A 通过诱导 NAG-1 表达抑制肝癌细胞迁移。
Acta Pharmacol Sin. 2022 Mar;43(3):724-734. doi: 10.1038/s41401-021-00695-4. Epub 2021 Jun 11.
8
Adjuvant treatment in lung cancer.肺癌的辅助治疗。
J Clin Transl Res. 2021 Apr 16;7(2):175-184. eCollection 2021 Apr 22.
9
Recent advances in early stage lung cancer.早期肺癌的最新进展
J Clin Transl Res. 2021 Apr 6;7(2):163-174. eCollection 2021 Apr 22.
10
Current role of nanoparticles in the treatment of lung cancer.纳米颗粒在肺癌治疗中的当前作用。
J Clin Transl Res. 2021 Mar 16;7(2):140-155. eCollection 2021 Apr 22.